Lyra Therapeutics, Inc. (LYRA)
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.
$18.39M
Dr. Maria Palasis Ph.D.
59.00
Watertown, MA
May 01, 2020
-0.18
$-1.56
1.66
3.60
-5,570.88%
-0.18
-0.00
0.59
10.00
3.60
-107.20%
-143.74%
Similar stocks (9)
Day One Biopharmaceuticals, Inc.
DAWN
Cullinan Oncology, Inc.
CGEM
Nuvation Bio Inc.
NUVB
Instil Bio, Inc.
TIL
Assembly Biosciences, Inc.
ASMB
CytomX Therapeutics, Inc.
CTMX
Spero Therapeutics, Inc.
SPRO
NextCure, Inc.
NXTC
Bolt Biotherapeutics, Inc.
BOLT
ETF Exposure (13)
iShares Micro-Cap ETF
IWC
0.00367%
iShares Russell 2000 Growth ETF
IWO
0.00102%
iShares Russell 2000 ETF
IWM
0.001%
ProShares Ultra Russell2000
UWM
2.0445512628469126e-4%
ProShares UltraPro Russell2000
URTY
1.0076024991768663e-4%
ProShares Hedge Replication ETF
HDG
8.59881594124973e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (9)
Day One Biopharmaceuticals, Inc.
DAWN
Cullinan Oncology, Inc.
CGEM
Nuvation Bio Inc.
NUVB
Instil Bio, Inc.
TIL
Assembly Biosciences, Inc.
ASMB
CytomX Therapeutics, Inc.
CTMX
Spero Therapeutics, Inc.
SPRO
NextCure, Inc.
NXTC
Bolt Biotherapeutics, Inc.
BOLT
ETF Exposure (13)
iShares Micro-Cap ETF
IWC
0.00367%
iShares Russell 2000 Growth ETF
IWO
0.00102%
iShares Russell 2000 ETF
IWM
0.001%
ProShares Ultra Russell2000
UWM
2.0445512628469126e-4%
ProShares UltraPro Russell2000
URTY
1.0076024991768663e-4%
ProShares Hedge Replication ETF
HDG
8.59881594124973e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%